Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO-IL-11)
The Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO; IL-11) as of January 2011 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects. Competitor projects are listed in a tabular format providing information on:
Index
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Index
- TPO-R Activators
- IL-11-R Activators
- Small Molecule TPO Agonists
- Others
- Corporate TPO/IL-11 Receptor Agonist R&D Pipelines
- About La Merie
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.